NSE · MANKIND
Mankind Pharma Limited (MANKIND) Share Price
Historical price visualisation is temporarily undergoing corporate data-licensing maintenance. Full interactive price and chart data will return following our upcoming authorized NSE/BSE data-feed deployment. Derived metrics (valuation ratios, market-cap rank), company financials, shareholding, corporate actions, and mutual-fund holdings remain available.
Market cap rank
#112
of 5,047 stocks
▲ 11W▲ 91M
Peak #102 · 02 Oct 2026
Operating in Healthcare, Mankind Pharma Limited carries a steep earnings multiple that prices in strong future growth, remains firmly promoter-controlled, with promoters holding 73%, and is growing revenue at a solid clip.
Market Cap
108,478.58 Cr
P/E Ratio
56.67
P/B Ratio
6.55
ROE
11.70%
ROCE
14.32%
Dividend Yield
—
52W High
—
52W Low
—
Quarterly financials
| Metric | Q2 2026-27 | Q1 2026-27 | Q4 2025-26 | Q3 2025-26 |
|---|---|---|---|---|
| Revenue | 4,337.86 Cr | 4,030.59 Cr | 3,442.93 Cr | 3,567.20 Cr |
| Net Profit | 716.12 Cr | 574.09 Cr | 559.42 Cr | 413.88 Cr |
| EPS | 17.23 | 13.76 | 13.44 | 9.90 |
| Operating Profit | 1,030.37 Cr | 875.49 Cr | 821.09 Cr | 769.58 Cr |
Shareholding pattern
Promoter
72.63%
Public
27.37%
PUBLIC BREAKDOWN
FII
9.45%
DII
15.39%
MF (within DII)
10.87%
Individuals
1.34%
Mutual fund holdings
₹10,527.49
Cr total
221
Schemes
33
Fund Houses
₹10,527.49 Cr
Total Exposure
Nippon India Mutual Fund₹2,557.61 Cr (24.3%)
SBI Mutual Fund₹1,504.91 Cr (14.3%)
Aditya Birla Sun Life Mutual Fund₹1,309.58 Cr (12.4%)
HDFC Mutual Fund₹737.49 Cr (7.0%)
Franklin Templeton Mutual Fund₹625.10 Cr (5.9%)
Others₹3,792.80 Cr (36.0%)
| Scheme | Fund House | Value (Cr) | % |
|---|
Recent corporate actions
| Ex-Date | Type | Details |
|---|---|---|
| 08 Aug 2025 | Dividend | Interim Dividend - Re 1 Per Share |
Other Healthcare stocks
Need this data in your app?
Full price history, technical indicators, and every field above via one REST API call.